Home/Micar Innovation/Filip Fratev
FF

Filip Fratev

Management Team

Micar Innovation

Micar Innovation Pipeline

DrugIndicationPhase
PPARγ ProgramMetabolic DisordersDiscovery
AKT1 Inhibitor ProgramOncologyDiscovery
GlyT2 Inhibitor ProgramNeurological DisordersDiscovery
Cardiovascular Target ProgramHypertrophic CardiomyopathyDiscovery